Psyence Group Inc. (PSYGF)
Psyence Group Inc. operates in the Drug Manufacturers - General industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.14, up 9.76% on the session, giving a market capitalisation of $2.2M. On trailing twelve-month figures it carries a trailing P/E of -0.21, a net margin of 0.0%. Its beta of 1.31 implies it has historically moved more than the broad market.
Psyence Group, Inc. is a life science biotechnology company, which engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma in the context of palliative care and in support of mental wellness. Its divisions include Psyence Production and Psyence Therapeutics. The company was founded by Jody Aufrichtig on March 26, 1994 and is headquartered in Toronto, Canada.
Psyence Group Inc. is most often compared with the following Healthcare names: